High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter - PubMed (original) (raw)
. 1996 Oct 1;224(1):281-91.
doi: 10.1006/viro.1996.0530.
Affiliations
- PMID: 8862423
- DOI: 10.1006/viro.1996.0530
Free article
High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter
D Apt et al. Virology. 1996.
Free article
Abstract
Gene expression of human papillomavirus type 16 (HPV-16) and other HPV types is epithelial specific. Specificity is brought about by synergism between several different transcription factors that seem to occur ubiquitously but differ qualitatively and quantitatively between cells in which HPV genomes are transcriptionally active or inactive. Here, we report on the contribution to this combinatorial mechanism by the activator Sp1 and the related antagonist Sp3, both of which can bind a single site at the E6 promoter of all genital HPVs. In the Sp-factor-free background of Drosophila cells, Sp1 activates HPV-16 transcription, while Sp3 fails to do so and even inhibits the activation by Sp1. The same differential activation occurs in the case of promoters of the epithelial-specific cellular genes encoding keratin 18 and E-cadherin. All cell types that we examined contain similar amounts of Sp3 factor. In contrast, Sp1 levels, determined by supershifts and Western blots, are higher in several human epithelial cell lines that support HPV transcription than in human fibroblasts, liver, and muscle cells. This suggests that cell-type differential transcription is regulated by Sp1 and Sp3. In primary keratinocytes, Sp3 levels exceed those of Sp1. This ratio became inverted after differentiating these cells in high calcium, or methyl cellulose containing medium. The simultaneous transcriptional stimulation of the HPV promoter points to a role of the Sp1-Sp3 antagonism during a differentiation of stratified epithelia in vivo, as these culture techniques mimick this process in vitro. Transformation in vivo or in vitro seems to override these cell-type-specific controls and leads to a general increase of Sp1 activity.
Similar articles
- Laminin reduces expression of the human alpha6 integrin subunit gene by altering the level of the transcription factors Sp1 and Sp3.
Gaudreault M, Vigneault F, Leclerc S, Guérin SL. Gaudreault M, et al. Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3490-505. doi: 10.1167/iovs.07-0016. Invest Ophthalmol Vis Sci. 2007. PMID: 17652716 - Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts.
Le Mée S, Fromigué O, Marie PJ. Le Mée S, et al. Exp Cell Res. 2005 Jan 1;302(1):129-42. doi: 10.1016/j.yexcr.2004.08.028. Exp Cell Res. 2005. PMID: 15541732 - Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
Lou Z, Maher VM, McCormick JJ. Lou Z, et al. Gene. 2005 May 23;351:51-9. doi: 10.1016/j.gene.2005.02.007. Epub 2005 Apr 25. Gene. 2005. PMID: 15857802 - [HPV16 participates in progressive transformation of normal epidermal cells].
Yasumoto S. Yasumoto S. Gan To Kagaku Ryoho. 1989 Mar;16(3 Pt 2):549-61. Gan To Kagaku Ryoho. 1989. PMID: 2539784 Review. Japanese. - The role of Sp1 and Sp3 in normal and cancer cell biology.
Li L, Davie JR. Li L, et al. Ann Anat. 2010 Sep 20;192(5):275-83. doi: 10.1016/j.aanat.2010.07.010. Epub 2010 Aug 6. Ann Anat. 2010. PMID: 20810260 Review.
Cited by
- The Hallmarks of Cervical Cancer: Molecular Mechanisms Induced by Human Papillomavirus.
Rosendo-Chalma P, Antonio-Véjar V, Ortiz Tejedor JG, Ortiz Segarra J, Vega Crespo B, Bigoni-Ordóñez GD. Rosendo-Chalma P, et al. Biology (Basel). 2024 Jan 27;13(2):77. doi: 10.3390/biology13020077. Biology (Basel). 2024. PMID: 38392296 Free PMC article. Review. - Potential role of human papillomavirus proteins associated with the development of cancer.
Balaji D, Kalarani IB, Mohammed V, Veerabathiran R. Balaji D, et al. Virusdisease. 2022 Sep;33(3):322-333. doi: 10.1007/s13337-022-00786-8. Epub 2022 Aug 27. Virusdisease. 2022. PMID: 36277412 Free PMC article. Review. - An Overview of HPV Screening Tests to Improve Access to Cervical Cancer Screening Amongst Underserved Populations: From Development to Implementation.
Okunade KS, Adejimi AA, John-Olabode SO, Oshodi YA, Oluwole AA. Okunade KS, et al. Risk Manag Healthc Policy. 2022 Sep 23;15:1823-1830. doi: 10.2147/RMHP.S296914. eCollection 2022. Risk Manag Healthc Policy. 2022. PMID: 36176779 Free PMC article. Review. - Human Papillomavirus Infection in Head and Neck Squamous Cell Carcinomas: Transcriptional Triggers and Changed Disease Patterns.
Aggarwal N, Yadav J, Thakur K, Bibban R, Chhokar A, Tripathi T, Bhat A, Singh T, Jadli M, Singh U, Kashyap MK, Bharti AC. Aggarwal N, et al. Front Cell Infect Microbiol. 2020 Dec 2;10:537650. doi: 10.3389/fcimb.2020.537650. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 33344262 Free PMC article. Review. - Prevalence of antibodies against a cyclic peptide mimicking the FG loop of the human papillomavirus type 16 capsid among Tunisian women.
Hassen E, Bansal D, Ghdira R, Chaieb A, Khairi H, Zakhama A, Remadi S, Hoebeke J, Sultan AA, Chouchane L. Hassen E, et al. J Transl Med. 2020 Jul 29;18(1):288. doi: 10.1186/s12967-020-02450-5. J Transl Med. 2020. PMID: 32727491 Free PMC article.